Search
for
Sort by
Research 30 of 1000+
- Vitiligo and Alopecia Areata as Early Signs Preceding Type 1 Diabetes Mellitus
- Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report
- Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)
- Higher Levels of Steroidogenic Acute Regulatory Protein and Type I 3β-Hydroxysteroid Dehydrogenase in the Scalp of Men with Androgenetic Alopecia
- Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- Type D Personality, Stress Levels, and Coping Strategies in Women with Androgenetic Alopecia and Polycystic Ovary Syndrome
- Efficacy of type A botulinum toxin treatment for androgenetic alopecia using ultrasound combined with trichoscopy
- Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector
- Comparison of androgenic alopecia distribution among type 2 diabetes and healthy women in Isfahan city: a brief report
- Mesotherapy for Treatment of Male-Type Alopecia
- Alterations of collagen type 1, skin fibroblasts, and macrophages in the scalp following the treatment of 1550‐nm erbium glass fractional laser for androgenetic alopecia
- Inhibitory effect of angiogenin on the expression of type I collagen and fibronectin in dermal papilla cells from androgenetic alopecia areas
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis
- Frontal Alopecia after Repeated Botulinum Toxin Type A Injections for Forehead Wrinkles: An Underestimated Entity?
- Radiation-induced Alopecia Treated with Botulinum Toxin Type A Injection
- Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia
- Autoimmune polyglandular syndrome type 2, alopecia universalis and Crohn's disease
- Discovery of 7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1<i>H</i>-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): A Potent and Selective Transforming Growth Factor-β Type I Receptor Inhibitor as a Topical Drug for Alopecia
- Rickets with Alopecia Signals Vitamin D Dependent Rickets Type II
- A RARE CASE OF SIMULATANEOUS DEVELOPMENT OF ALOPECIA AREATA UNIVERSALIS AND TYPE 1 DIABETES MELLITUS
- A Rare Type of Radiation-Induced Alopecia: Proton-Induced Alopecia
- Expression of collagen type I, skin fibroblasts and macrophages after 1550 nm erbium glass fractional laser in androgenic alopecia
- Alopecia Areata Developing in Non-Insulin Dependent Diabetes Mellitus Type-2, an Autoimmune Disease
- The type of androgenetic alopecia and quality of life (QoL) in male patients
- Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia